United Kingdom

How we help

Following the United Kingdom leaving the EU in 2020, and the resulting impact on the market, regulatory environment and supply chains, it has become more critical than ever for pharmaceutical and biotech companies to get their approach right. 

It requires a partner with a proven track record in enabling access to medicines across all markets – clinical, unlicensed and commercial. A partner with the capability to deliver those medicines to the hospitals and pharmacies that need them, no matter the logistical challenge.

That’s where Clinigen comes in.

With 540+ employees across the UK, and more than 30 years of expertise in regulatory, medicine access, quality assurance, logistics and marketing, Clinigen have the experience and reach to ensure access to medicines in all phases of the lifecycle, pre- and post-launch.

Clinigen’s strong relationships with suppliers, hospitals, pharmacies and regulatory bodies, as well as an expert global sourcing team and distribution network, ensure healthcare professionals can always get the right medicine for their patient, whether licensed, yet to launch or in shortage.

To find out more about how we can help, please get in touch.